<?xml version="1.0" encoding="UTF-8"?>
<p>During prior influenza epidemics, more patients died of CV causes than pneumonia/influenza causes [
 <xref rid="B49-jcm-09-01407" ref-type="bibr">49</xref>]. Given the high inflammatory burden of COVID-19, significant CV complications with COVID-19 infection are expected. Previous reports have suggested that COVID-19 leads to CV complications or deterioration of pre-existing CVD [
 <xref rid="B7-jcm-09-01407" ref-type="bibr">7</xref>,
 <xref rid="B8-jcm-09-01407" ref-type="bibr">8</xref>,
 <xref rid="B20-jcm-09-01407" ref-type="bibr">20</xref>,
 <xref rid="B42-jcm-09-01407" ref-type="bibr">42</xref>,
 <xref rid="B50-jcm-09-01407" ref-type="bibr">50</xref>]. The potential CV complications following COVID-19 are described in 
 <xref rid="jcm-09-01407-t002" ref-type="table">Table 2</xref> and 
 <xref ref-type="fig" rid="jcm-09-01407-f001">Figure 1</xref>.
</p>
